Clinical trial Recruiting at 1 site Observational Ages 18 to 99

Using Nanopore Sequencing to Identify Pathogens in Eye Infections

Official title: Nanopore Sequencing in Ophthalmology - a Paradigm Shift in Pathogen Determination?

Run by Medical University of Graz · NCT05372861 · Data updated 2026-11-12

This study is testing whether a new device can quickly identify germs causing eye infections in patients undergoing surgery, to see if it works better than the usual methods.

Quick facts

Study typeObservational
Ages18 Years to 99 Years
SexAll
Enrollment20 (estimated)
SponsorMedical University of Graz
Academic / other
Locations1 site (Graz, Styria)
StatusRecruiting
StartedApril 22, 2022
Main results expectedDecember 1, 2026
Study endsDecember 1, 2027
Registry record updatedOctober 20, 2026
Trial IDNCT05372861 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with endophthalmitis who are undergoing vitrectomy.

Probably not a fit

Patients who are unable to provide informed consent or are participating in other studies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study assesses the feasibility of using the Oxford Nanopore MinION device to identify pathogens in vitrectomy samples from patients with endophthalmitis. During routine vitrectomy, vitreous samples and anterior chamber taps are collected and split for both standard microbial culture and nanopore sequencing. The results from nanopore sequencing are then compared to traditional culture methods to evaluate their effectiveness in pathogen identification. Clinical data regarding visual function and other features are also collected to provide a comprehensive overview of patient outcomes.

Why it matters

Potential benefit: If successful, this approach could lead to faster and more accurate identification of pathogens in endophthalmitis, improving treatment outcomes for patients.

How similar studies have gone: While the use of nanopore sequencing in infectious diseases is promising, this specific application in ophthalmology is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Eyes of patients with endophthalmitis

Exclusion Criteria:

* No informed consent possible
* Participation in other studies

Where it's running

  • Universitäts Augenklinik Graz
    Graz, Styria, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.